Skip to main content
. 2016 Nov 22;8(1):679–691. doi: 10.18632/oncotarget.13510

Table 2. Sequenced sites of selected genes.

Genes Fragment Start/Stop Size (bp) Number of CpG sites
RASSF1 RASSF1_M1 50377767/50378028 261 21
RASSF1_M2 50378005/50378218 213 23
RASSF1_M3 50378194/50378472 278 27
RASSF1_M5 50375039/50375295 256 23
RASSF1_M6 50374899/50375126 227 19
RASSF1_M7 50374706/50374925 219 29
RASSF1_M9 50374301/50374516 215 13
PIK3R1 PIK3R1_M2 67511168/67511412 244 22
PIK3R1_M4 67511596/67511806 210 23
PIK3R1_M5 67511286/67511520 234 21
PIK3R1_M6 67511047/67511305 258 22
PIK3R1_M7 67512226/67512438 212 18
PIK3R1_M8 67584255/67584471 216 15
ITGAV ITGAV_M1 187454700/187454960 260 21
ITGAV_M2 187454936/187455177 241 32
ITGAV_M3 187455157/187455369 212 21
NFKB1 NFKB1_M2 103422534/103422795 261 37
NFKB1_M3 103422775/103422981 206 23
NFKB1_M4 103423077/103423302 225 18
TAP2 TAP2_M1 32806418/32806681 263 12
APC APC_M2 112073375/112073585 210 15
BRCA1 BRCA1_M1 41275281/41275523 242 18
BRCA1_M3 41275011/41275281 270 11
BRCA1_M4 41275268/41275528 260 12
CCND1 CCND1_M3 69458670/69458890 220 14
CDKN2A CDKN2A-2 21993123/21993331 208 20
CDKN2A-4 21993770/21993957 187 16
CDKN2A-6 21994239/21994504 265 26
CDKN2A-7 21994477/21994700 223 11
CDKN2A_M8 21972954/21973198 244 11
CDKN2A_M9 21974670/21974872 202 15
CDKN2A_M10 21974852/21975095 243 20
BNIP3 BNIP3-1 133795927/133796159 232 10
BNIP3-3 133796371/133796631 260 33
BNIP3-6 133797020/133797250 230 26
BNIP3-7 133797230/133797402 172 16
HTATIP2 HTATIP2-1 20385087/20385355 268 24
HTATIP2-2 20385336/20385546 210 20
PRDM16 PRDM16-1 2983847/2984081 234 14
PRDM16-5 2984736/2984979 243 29
PRDM16-7 2985182/2985386 204 19
PRDM16-8 2985367/2985573 206 16
PRDM16-9 2985553/2985775 222 19
PTEN PTEN-1 89623758/89624026 268 21
PTX3 PTX3-1 157155257/157155524 267 9
PTX3-2 157155500/157155711 211 25
SOCS1 SOCS1-1 11349069/11349310 241 20
SOCS1-3 11349540/11349759 219 31